IRMD Key Statistics, Chart & Performance
The current stock price of IRMD is 98.95 USD. In the past month the price increased by 1.8%. In the past year, price increased by 74.85%.
IRMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About IRMD
Company Profile
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 160 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Company Info
IRADIMED CORP
12705 Ingenuity Drive
Orlando FLORIDA 32708 US
CEO: Roger Susi
Employees: 160
Phone: 14076778022
IRADIMED CORP / IRMD FAQ
Can you describe the business of IRADIMED CORP?
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 160 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Can you provide the latest stock price for IRADIMED CORP?
The current stock price of IRMD is 98.95 USD. The price decreased by -1.05% in the last trading session.
What is the dividend status of IRADIMED CORP?
IRADIMED CORP (IRMD) has a dividend yield of 0.68%. The yearly dividend amount is currently 1.08.
What is the ChartMill rating of IRADIMED CORP stock?
IRMD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
On which exchange is IRMD stock listed?
IRMD stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of IRADIMED CORP (IRMD)?
The PE ratio for IRADIMED CORP (IRMD) is 54.37. This is based on the reported non-GAAP earnings per share of 1.82 and the current share price of 98.95 USD.
Is IRADIMED CORP (IRMD) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IRMD.
IRMD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to IRMD. When comparing the yearly performance of all stocks, IRMD is one of the better performing stocks in the market, outperforming 93.47% of all stocks.
IRMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to IRMD. IRMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
IRMD Financial Highlights
Over the last trailing twelve months IRMD reported a non-GAAP Earnings per Share(EPS) of 1.82. The EPS increased by 13.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.31% | ||
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| Debt/Equity | 0 |
IRMD Forecast & Estimates
8 analysts have analysed IRMD and the average price target is 100.98 USD. This implies a price increase of 2.05% is expected in the next year compared to the current price of 98.95.
For the next year, analysts expect an EPS growth of 15.29% and a revenue growth 13.26% for IRMD